Tag Archives: Task Force for Global Health

Research!America’s Advocacy Awards are tonight!

Research!America will honor extraordinary leaders in biomedical and health research advocacy at the 17th Annual Advocacy Awards tonight, March 13, at the Andrew W. Mellon Auditorium in Washington, DC. This year’s Advocacy Award Winners are: Sens. Richard Burr (R-NC) and Bob Casey (D-PA); Diane Rehm, author and host of WAMU 88.5 and NPR’s “The Diane Rehm Show”; John F. Crowley, patient advocate, inspirational entrepreneur, and chairman and CEO of Amicus Therapeutics, Inc.; John Mendelsohn, MD, director, Khalifa Institute for Personalized Cancer Therapy and former president of The University of Texas MD Anderson Cancer Center; Mark Rosenberg, MD, president and CEO, The Task Force for Global Health; and the California Institute for Regenerative Medicine (CIRM).

“The leadership demonstrated by this year’s award recipients has inspired others to push boundaries to improve the health of Americans and maintain our competitive edge in science and innovation,” said Mary Woolley, president and CEO of Research!America. “As advocates, they have contributed significantly to making biomedical and health research a higher national priority.”

Follow Research!America on Twitter (@researchamerica) and visit our Facebook page to get more information about tonight’s event. Look for photos of the Awards Dinner on our Flickr account and video clips on our YouTube page in the coming days.

For more information about the honorees, visit www.researchamerica.org/advocacy_awards and read our latest press release. You can also follow news updates from our honorees. Read Senator Burr’s blog and news from Senator Casey; visit The Diane Rehm Show’s Facebook page; don’t miss the Crowley family’s website and Amicus Therapeutics news; keep up with news about Mendelsohn and the Institute for Personalized Cancer Therapy; Rosenberg and the Task Force for Global Health’s online news room is full of great information; and don’t miss CIRM’s blog.

Advertisements

Research!America Hosts NTD Panel at CUGH Conference

Did you know that neglected tropical diseases such as dengue, Chagas and hookworm affect over 1.4 billion people worldwide, including individuals here in the U.S.? To discuss the global burden of NTDs and how federal funding and policy decisions impact the research and development of tools to combat these diseases around the world, Research!America will be hosting a panel at the Consortium of Universities for Global Health (CUGH) conference*. The panel, “Are NTDs a Growing Threat? Research, Access and Next Steps,” will be held on Thursday, March 14 at 1:30 p.m. at the Marriott Wardman Park Hotel.

The conversation will be moderated by Karen Goraleski, Executive Director of the American Society of Tropical Medicine and Hygiene (ASTMH) and will feature the following panelists: Rachel Cohen, Regional Executive Director of the Drugs for Neglected Diseases initiative (DNDi); Brian D’Cruz, Emergency Physician with Doctors Without Borders/Médecins Sans Frontières North America; LeAnne Fox, Medical Officer and Team Lead on NTDs at the Centers for Disease Control and Prevention (CDC); Kristy Murray, Associate Professor of Pediatrics at the National School of Tropical Medicine, Baylor College of Medicine and Mark Rosenberg, President and CEO of the Task Force for Global Health.

*Please note that attendance at the CUGH conference requires registration fees. For more information, please visit the conference website here.

Task Force for Global Health Receives Grant for NTD Research

On February 5, the Task Force for Global Health, a non-profit based in Decatur, Georgia announced that it received a $28.8 million, five-year grant from the Gates Foundation for neglected tropical disease research. This funding will support the new Neglected Tropical Diseases Support Center and will allow the center to work with the NTD community to address challenges in implementing NTD control programs. The Center will focus primarily on operational research and will work to develop new solutions to increase the efficiency and cost-effectiveness of NTD interventions. The grant will also support the development of a “Coalition for Operational Research for NTDs,” which will allow for more collaboration between international NTD researchers. Awarded just over a year after the London Declaration on NTDs, this grant is an important step forward in the fight against NTDs as it “will support the research needed to eliminate and control these dreaded diseases.”

-Morgan McCloskey, global health intern